Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-Lowering drugs

H. M. Colhoun*, S. J. Livingstone, H. C. Looker, A. D. Morris, S. H. Wild, R. S. Lindsay, C. Reed, P. T. Donnan, B. Guthrie, G. P. Leese, J. McKnight, D. W.M. Pearson, E. Pearson, J. R. Petrie, S. Philip, N. Sattar, F. M. Sullivan, P. McKeigue

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

130 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-Lowering drugs'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science